Results 11 to 20 of about 57,826 (262)
Effect of Intravenous IgM-Enriched Immunoglobulins on Presepsin and Other Sepsis Biomarkers
Frontiers in Pharmacology, 2021 Patients in septic shock with low IgG and IgM serum concentrations have higher mortality rates compared to those with normal immunoglobulin levels and, therefore, there is a rational explanation to administer intravenous IgM-enriched immunoglobulins to ...
Giuliana Scarpati +7 more
doaj +1 more source
LIVEdoid vasculopathy – benefit of intravenous immunoglobulin in a refractory case [PDF]
Romanian Journal of Rheumatology, 2021 Livedoid vasculopathy is a rare vascular disease which typically manifests as recurrent ulcerative lesions on the lower extremities. It is classified as a vasculopathy, not a true vasculitis, and defined as a vasooclusive syndrome, caused by non ...
Stefan Cristian Dinescu +7 more
doaj +1 more source
Prurigo nodularis responding to intravenous immunoglobulins
Przegląd Dermatologiczny, 2022 Prurigo nodularis is a chronic skin disease, especially seen in middle-aged women adults. It is characterized by symmetric, pruritic hyperkeratotic nodules and papules on the extensor surfaces [1].
Koray Durmaz +3 more
doaj +1 more source
Case Reports in Women's Health, 2022 Gestational alloimmune liver disease is a rare complication associated with reactive maternal immunoglobulins resulting in neonatal liver pathology. The mainstay treatment for prevention in future pregnancies is intravenous immunoglobulins.
Minhazur Sarker +2 more
doaj +1 more source
Immunological Medicine, 2022 Currently, no standard treatment strategy has been established for immune-mediated necrotizing myopathy (IMNM). Here we present a case of IMNM which was successfully treated with intensive combined therapy with high-dose glucocorticoids, tacrolimus, and ...
Tatsuya Shimada +7 more
doaj +1 more source
Intravenous Immunoglobulins in a Series of 32 Rare and Recalcitrant Immune Dermatoses
Acta Dermato-Venereologica, 2020 Intravenous immunoglobulins are an effective and well-tolerated treatment option for immune dermatological diseases. However, they are primarily used to treat diseases with a severe course and are mostly used off-label.
Roberta Scarpone +3 more
doaj +1 more source
Use of Intravenous Immunoglobulins in Intensive Therapy
Общая реаниматология, 2012 The main cause of death in the intensive care units is infectious complications, including sepsis and septic shock. Immunoglobulins are the most potent mechanisms in anti-infective defense.
E. A. Latysheva, T. V. Latysheva
doaj +1 more source
Immunoglobulins in neurological practice: a review of the literature
Нервно-мышечные болезни, 2019 Today intravenous immunoglobulins are used increasingly in the management of patients with neurological conditions. The efficacy and safety of intravenous immunoglobulins treatment in chronic inflammatory demyelinating polyradiculoneuropathy, Guillain ...
S. S. Nikitin, L. M. Boriskina
doaj +1 more source
Case Reports in Pulmonology, 2021 Fewer than ten reported cases of cryptogenic organizing pneumonia (COP) have been managed with intravenous immunoglobulins (IVIg). We report a case of a 72-year-old man who presented with a worsening cough and diffuse opacities on chest radiograph ...
Christian Akem Dimala +6 more
doaj +1 more source
Use of intravenous immunoglobulin in neonates with haemolytic disease and immune thrombocytopenia [PDF]
Vojnosanitetski Pregled, 2013 Background/Aim. Intravenous immunoglobulin is a blood product made of human polyclonal immunoglobulin G. The mode of action of intravenous immunoglobulin is very complex.
Marković-Sovtić Gordana +4 more
doaj +1 more source